PAM
MBIO icon

PVG Asset Management’s Mustang Bio MBIO Stock Holding History

PVG Asset Management’s Portfolio MBIO Stock Details MBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$24.7K Buy
+20
New +$32.3K 0.09% 46

Other funds holding MBIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

PVG Asset Management's MBIO Position: Q4 2021 in Review

PVG Asset Management opened a new position in Mustang Bio (MBIO) in Q4 2021: 20 shares worth $24.7K. The stake represents 0.09% of the portfolio and ranks #46 among its holdings.

83 funds tracked by Wall St. Rank hold MBIO as of Q4 2021.

  • PVG Asset Management held 20 shares of Mustang Bio worth $24.7K as of Q4 2021.
  • Mustang Bio was a new PVG Asset Management position in Q4 2021.
  • Mustang Bio made up 0.09% of PVG Asset Management's portfolio in Q4 2021, its #46 holding.
  • 83 funds tracked by Wall St. Rank held Mustang Bio as of Q4 2021.

Based on PVG Asset Management's 13F filing for Q4 2021, filed 2 Feb 2022.